AJP - Renal AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (September 27, 2005). doi:10.1152/ajprenal.00314.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/F486    most recent
00314.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Breen, L. T.
Right arrow Articles by Mutafova-Yambolieva, V. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breen, L. T.
Right arrow Articles by Mutafova-Yambolieva, V. N.
Submitted on August 3, 2005
Accepted on September 20, 2005

{beta}-NAD is a novel nucleotide released upon stimulation of nerve terminals in human urinary bladder detrusor muscle

Leanne T. Breen1, Lisa M. Smyth1, Ilia A. Yamboliev1, and Violeta N. Mutafova-Yambolieva1*

1 Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, Nevada, USA

* To whom correspondence should be addressed. E-mail: vnm{at}med.unr.edu.

Endogenous nucleotides with extracellular functions may be involved in the complex neural control of human urinary bladder (HUB). Using high performance liquid chromatography (HPLC) techniques with fluorescence detection we observed that in addition to adenosine 5'-triphosphate (ATP) and its metabolites ADP, AMP and adenosine, electrical field stimulation (EFS, 4-16 Hz, 0.1 ms, 15 V, 60 s) of HUB detrusor smooth muscle co-releases novel nucleotide factors, which produce etheno-1N6- ADP-ribose (eADPR) upon etheno-derivatization at high temperature. A detailed HPLC fraction analysis determined that nicotinamide adenine dinucleotide ({beta}-NAD+, 7.0±0.7 fmol/mg tissue) is the primary nucleotide that contributes to the formation of eADPR. The tissue superfusates collected during EFS also contained the {beta}-NAD+ metabolite ADPR (0.35±0.2 fmol/mg tissue) but not cyclic ADPR (cADPR). HUB failed to degrade nicotinamide guanine dinucleotide (NGD), a specific substrate of ADP ribosyl cyclase, suggesting that the activity of this enzyme in the HUB is negligible. The EFS-evoked release of {beta}-NAD+ was frequency dependent and is reduced in the presence of tetrodotoxin (TTX, 0.3 µmol/L), {omega}-conotoxin GVIA (50 nmol/L) and botulinum neurotoxin A (BoNT/A, 100 nmol/L), but remained unchanged in the presence of guanethidine (3 µmol/L), {omega}-agatoxin IVA (50 nmol/L), or charbachol (1 µmol/L). Capsaicin (10 µmol/L) increased both the resting and EFS-evoked overflow of {beta}-NAD+. Exogenous {beta}-NAD+ (1 µmol/L) reduced both the frequency and amplitude of spontaneous contractions. In conclusion, we detected nerve-evoked overflow of {beta}-NAD+ and ADPR in HUB. The {beta}-NAD+/ADPR system may constitute a novel inhibitory extracellular nucleotide mechanism of neural control of the human bladder.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.